Advertisement

Looking at the Big Neurochemical Picture of Autism Spectrum Disorder

  • Natalia Jaworska
    Correspondence
    Address correspondence to Natalia Jaworska, Ph.D., Clinical EEG & Neuroimaging Laboratory, Royal’s Institute of Mental Health Research, Room 3129, 1145 Carling Ave, Ottawa ON K1Z7K4, Canada.
    Affiliations
    The Royal’s Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada
    Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Brain and Mind Research Institute, University of Ottawa, Ottawa, Ontario, Canada
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 174
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ford T.C.
        • Crewther D.P.
        A comprehensive review of the (1)H-MRS metabolite spectrum in autism spectrum disorder.
        Front Mol Neurosci. 2016; 9: 14
        • Grzadzinski R.
        • Huerta M.
        • Lord C.
        DSM-5 and autism spectrum disorders (ASDs): An opportunity for identifying ASD subtypes.
        Mol Autism. 2013; 4: 12
        • Wing L.
        • Potter D.
        The epidemiology of autistic spectrum disorders: Is the prevalence rising?.
        Ment Retard Dev Disabil Res Rev. 2002; 8: 151-161
        • Weintraub K.
        The prevalence puzzle: Autism counts.
        Nature. 2011; 479: 22-24
        • Kennedy S.H.
        • Downar J.
        • Evans K.R.
        • Feilotter H.
        • Lam R.W.
        • MacQueen G.M.
        • et al.
        The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in response prediction.
        Curr Pharm Des. 2012; 18 (5976–5389)
        • O’Neill J.
        • Bansal R.
        • Goh S.
        • Rodie M.
        • Sawardekar S.
        • Peterson B.S.
        Parsing the heterogeneity of brain metabolic disturbances in autism spectrum disorder.
        Biol Psychiatry. 2020; 87: 174-184
        • Ramadan S.
        • Lin A.
        • Stanwell P.
        Glutamate and glutamine: A review of in vivo MRS in the human brain.
        NMR Biomed. 2013; 26: 1630-1646
        • Di Martino A.
        • Yan C.G.
        • Li Q.
        • Denio E.
        • Castellanos F.X.
        • Alaerts K.
        • et al.
        The autism brain imaging data exchange: Towards a large-scale evaluation of the intrinsic brain architecture in autism.
        Mol Psychiatry. 2014; 19: 659-667
        • Lilienfeld S.O.
        • Treadway M.T.
        Clashing diagnostic approaches: DSM-ICD versus RDoC.
        Annu Rev Clin Psychol. 2016; 12: 435-453
        • Damiano C.R.
        • Mazefsky C.A.
        • White S.W.
        • Dichter G.S.
        Future directions for research in autism spectrum disorders.
        J Clin Child Adolesc Psychol. 2014; 43: 828-843

      Linked Article

      • Parsing the Heterogeneity of Brain Metabolic Disturbances in Autism Spectrum Disorder
        Biological PsychiatryVol. 87Issue 2
        • Preview
          Despite rising prevalence of autism spectrum disorder (ASD), its brain bases remain uncertain. Abnormal levels of N-acetyl compounds, glutamate+glutamine, creatine+phosphocreatine, or choline compounds measured by proton magnetic resonance spectroscopy suggest that neuron or glial density, mitochondrial energetic metabolism, and/or inflammation contribute to ASD neuropathology. The neuroanatomic distribution of these metabolites could help evaluate leading theories of ASD. However, most prior magnetic resonance spectroscopy studies had small samples (all <60, most <20), interrogated only a small fraction of the brain, and avoided assessing effects of age, sex, and IQ.
        • Full-Text
        • PDF